Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
10 Feb 2022
Change of Director's Interest Notice - Jane Bell
01 Feb 2022
Amplia Investor Presentation - February 2022
24 Jan 2022
Quarterly Activities and Cashflow Reports - Dec 2021 Qtr
19 Jan 2022
Notification regarding unquoted securities - ATX
13 Jan 2022
Amplia Completes Manufacture of AMP945 for Planned Trials
Previous
1
2
3
4
5
6
